@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo;
a np:Nanopublication .
}
sub:assertion {
sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
sub:version prov:value "1"^^xsd:integer .
rdf:object ns2:C0030705 "patients";
ns2:C4726677 "remdesivir" .
rdf:predicate ns1:TRIPLE_UID:81qoau7o-TRIPLE-ABSTRACT-1 "administer" .
rdf:subject ns2:C0011777 "dexamethasone";
ns2:C0019134 "heparin";
ns2:C0770546 "heparin";
ns2:C0907850 "ciclesonide";
ns2:C1138226 "Favipiravir";
ns2:C5237592 "heparin" .
rdfs:Triple-UID ns3:TRIPLE_UID:81qoau7o-TRIPLE-ABSTRACT-1 "81qoau7o-TRIPLE-ABSTRACT-1" .
rdfs:sentence rdfs:label "Favipiravir, ciclesonide, dexamethasone, and heparin were administered in 106, 168, 65, and 38 patients, respectively, but not remdesivir." .
rdfs:triple rdfs:label "Favipiravir , ciclesonide , dexamethasone , and heparin administered in 106 , 168 , 65 , and 38 patients , respectively , but not remdesivir" .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-07-25T21:46:25.209413"^^xsd:dateTime .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "MtJszUpV5Hk2RHJU1H7FkLgeJ1yS6+fbN0bDzZhHbV547/VxGI7kfC/FO/feZzG/Iw/5Up873vR8XXYm6EUSO49JRHIiyIRqaup3NtyynF088IC0UAFEpKSdBEMuaqZrGfrC4pNOIfnD+8f52Klk/nt24kgSdxRzENRaHcVlk+M=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-07-25T21:46:25.209413"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}